SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950103-18-007524
Filing Date
2018-06-19
Accepted
2018-06-19 06:25:13
Documents
2
Group Members
ROCHE FINANCE LTDROCHE HOLDINGS, INC.

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D/A dp92385_sc13da.htm SC 13D/A 62108
2 EXHIBIT 99.1 dp92385_ex9901.htm EX-99.1 463279
  Complete submission text file 0000950103-18-007524.txt   526984
Mailing Address ROCHE HOLDING, LTD. GRENZACHERSTRASSE 124 BASEL V8 CH-4070
Business Address ROCHE HOLDING, LTD. GRENZACHERSTRASSE 124 BASEL V8 CH-4070 9732354295
ROCHE HOLDING LTD (Filed by) CIK: 0000889131 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8
Type: SC 13D/A
SIC: 8880 American Depositary Receipts

Mailing Address 150 SECOND STREET CAMBRIDGE MA 02141
Business Address 150 SECOND STREET CAMBRIDGE MA 02141 617-418-2200
Foundation Medicine, Inc. (Subject) CIK: 0001488613 (see all company filings)

IRS No.: 271316416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87922 | Film No.: 18906162
SIC: 8071 Services-Medical Laboratories